SCHEMBL751633

SCHEMBL751633

O=C1NC=NC1=Cc1ccc(O)cc1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GSK3B P49841 2/20 0.50
METAP1 P53582 1/20 0.47
HPGD P15428 3/20 0.46
TDP1 Q9NUW8 2/20 0.46
AKR1B1 P15121 2/20 0.46
RAB9A P51151 1/20 0.46
ALDH1A1 P00352 4/20 0.44
MEN1 O00255 2/20 0.44
KMT2A Q03164 2/20 0.44
KDM4E B2RXH2 2/20 0.44
APEX1 P27695 1/20 0.44
CYP2C9 P11712 2/20 0.42
CYP1A2 P05177 1/20 0.42
CYP3A4 P08684 1/20 0.42
MRE11 P49959 1/20 0.41
NAT1 P18440 1/20 0.41
LMNA P02545 2/20 0.41
MAPT P10636 2/20 0.41
APAF1 O14727 1/20 0.41
THRB P10828 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3714349 1.00 GSK3B (0.50) GSK3BMETAP1HPGDTDP1AKR1B1
SCHEMBL751632 1.00 GSK3B (0.50) GSK3BMETAP1HPGDTDP1AKR1B1
SCHEMBL3714215 0.78 MAPT (0.54) METAP1HPGDTDP1RAB9AALDH1A1
SCHEMBL3714214 0.78 MAPT (0.54) METAP1HPGDTDP1RAB9AALDH1A1
SCHEMBL132173 0.75 GSK3B (0.50) GSK3BMETAP1HPGDTDP1AKR1B1
SCHEMBL132172 0.75 GSK3B (0.50) GSK3BMETAP1HPGDTDP1AKR1B1
SCHEMBL3711176 0.75 LRRK2 (0.41)
Hydrogen Peroxide SCHEMBL29033947 0.74 GSK3B (0.49) GSK3BMETAP1HPGDTDP1AKR1B1
SCHEMBL29899807 0.72 CLK1 (0.54) GSK3BRAB9AMEN1KMT2AKDM4E
SCHEMBL3720355 0.71 IGF1R (0.51) HPGDTDP1ALDH1A1MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 22 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-117186014-A HBI derivative, preparation method thereof, self-assembly body of HBI derivative and application of self-assembly body 江汉大学 2023-12-08 CN disclosed
US-11629131-B2 Coupled recognition/detection system for in vivo and in vitro use CORNELL UNIVERSITY (US) 2023-04-18 US disclosed
EP-3164411-B1 FLUOROGEN ACTIVATING AND SHIFTING TAG (FAST) PARIS SCIENCES LETTRES QUARTIER LATIN (FR) 2019-08-28 EP disclosed
US-20190185434-A1 COUPLED RECOGNITION/DETECTION SYSTEM FOR IN VIVO AND IN VITRO USE UNIV CORNELL (US) 2019-06-20 US disclosed
US-10316000-B2 Coupled recognition/detection system for in vivo and in vitro use CORNELL UNIVERSITY (US) 2019-06-11 US disclosed
EP-2398775-B1 COUPLED RECOGNITION/DETECTION SYSTEM FOR IN VIVO AND IN VITRO USE UNIV CORNELL (US) 2019-04-24 EP disclosed
US-10138278-B2 Fluorogen activating and shifting tag (FAST) PARIS SCIENCES ET LETTRES—QUARTIER LATIN (FR) 2018-11-27 US disclosed
CN-105420203-B Tyrosine analogue translation system and gene-encoded protein photoinduced electron transfer fluorescence sensor protein family 中国科学院生物物理研究所 2018-11-16 CN disclosed
US-20170137473-A1 FLUOROGEN ACTIVATING AND SHIFTING TAG (FAST) PARIS SCIENCES ET LETTRES (FR) 2017-05-18 US disclosed
EP-3164411-A2 FLUOROGEN ACTIVATING AND SHIFTING TAG (FAST) Paris Sciences et Lettres - Quartier Latin (FR) 2017-05-10 EP disclosed
US-8481307-B2 Modified fluorescent proteins and methods for using same EVROGEN JSC (RU) 2013-07-09 US disclosed
US-20120252699-A1 COUPLED RECOGNITION/DETECTION SYSTEM FOR IN VIVO AND IN VITRO USE CORNELL UNIVERSITY (US) 2012-10-04 US disclosed
US-20120094377-A1 Modified Fluorescent Proteins and Methods for Using Same EVROGEN JSC (RU) 2012-04-19 US disclosed
EP-2430156-A1 MODIFIED FLUORESCENT PROTEINS AND METHODS FOR USING SAME Evrogen Jsc (RU) 2012-03-21 EP disclosed
EP-2398775-A1 COUPLED RECOGNITION/DETECTION SYSTEM FOR IN VIVO AND IN VITRO USE Cornell University (US) 2011-12-28 EP disclosed
US-7972834-B2 Modified fluorescent proteins and methods for using same Evrogen IP Joint Stock Company (RU) 2011-07-05 US disclosed
US-20110003974-A1 Modified fluorescent proteins and methods for using same Evrogen IP Joint Stock Company (RU) 2011-01-06 US disclosed
WO-2010131115-A1 MODIFIED FLUORESCENT PROTEINS AND METHODS FOR USING SAME EVROGEN JSC (RU) 2010-11-18 WO disclosed
WO-2010122426-A2 METHODS AND COMPOSITIONS FOR VISUALIZATION OF FLUORESCENT PROTEINS EVROGEN JSC (RU) 2010-10-28 WO disclosed
WO-2010096584-A1 COUPLED RECOGNITION/DETECTION SYSTEM FOR IN VIVO AND IN VITRO USE CORNELL UNIVERSITY (US) 2010-08-26 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10138278-B2 Fluorogen activating and shifting tag (FAST) IK, FES, ATIC GSK3B 4830/4885METAP1 867/4885HPGD 3236/4885
US-20170137473-A1 FLUOROGEN ACTIVATING AND SHIFTING TAG (FAST) IK, FES, ATIC GSK3B 4830/4885METAP1 867/4885HPGD 3236/4885
US-11629131-B2 Coupled recognition/detection system for in vivo and in vitro use DCLRE1B, TLR9, APEX1 GSK3B 4643/4885METAP1 1389/4885HPGD 4853/4885
US-10316000-B2 Coupled recognition/detection system for in vivo and in vitro use DCLRE1B, TLR9, APEX1 GSK3B 4643/4885METAP1 1389/4885HPGD 4853/4885
US-20120252699-A1 COUPLED RECOGNITION/DETECTION SYSTEM FOR IN VIVO AND IN VITRO USE DCLRE1B, TLR9, APEX1 GSK3B 4643/4885METAP1 1389/4885HPGD 4853/4885
US-20190185434-A1 COUPLED RECOGNITION/DETECTION SYSTEM FOR IN VIVO AND IN VITRO USE DCLRE1B, TLR9, APEX1 GSK3B 4643/4885METAP1 1389/4885HPGD 4853/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.